 |
Sixth Annual
Research Day
Monday, June 19, 2006
9:00 am – 3:45 pm
Biomedical Science Tower First Floor Foyer and Room S-100
|
Abstracts for
Poster Presentations
-
Rebecca Abromitis, MLS
-
Carmen Andreescu,
M.D.
-
Miya R. Asato, M.D.
-
Joshua A. Bagley, B.S.
-
Mikhil
N. Bamne, Ph.D.
-
Srihari S. Bangalore, M.D.
-
Layla
Banihashemi, M.S.
-
Richard Blakesley-Ball, B.S.
-
Michael
R. Bykowski, B.Phil.
-
Raymond Y. Cho, M.D., M.Sc.
-
Kodavali V. Chowdari, Ph.D.
-
Nicole V. Christian, B.A.
-
Sarah M. Conklin, Ph.D.
-
Dianne A. Cruz, M.S.
-
Natacha M.
De Genna, Ph.D.
-
Mark Demidovich, M.D.
-
Rasim Somer Diler,
M.D.
-
Stephen M. Eggan, B.S.
-
Tiffany R. Farchione, M.D.
-
Erika E. Forbes, Ph.D.
-
Alison Gilbert, M.S. & Teresa Lanza di Scalea, M.D.
-
Andrew R. Gilbert, M.D.
-
Ariel G. Gildengers, M.D.
-
Christin A. Glorioso, B.S.
-
Indrani
Halder, Ph.D.
-
Takanori Hashimoto, M.D., Ph.D.
-
Michelle
Horner, D.O.
-
Nathan Hunnell
-
Morgen A. R. Kelly, Ph.D.
-
Natalie Kerr, M.Sc.
-
Cecile D. Ladouceur, Ph.D.
-
Xianchen Liu, M.D., Ph.D.
-
Irene M. Loe, M.D.
-
Jaime G. Maldonado-Avilés, B.S.
-
Pravat K. Mandal, Ph.D.
-
Reza Manesh
-
Rose C. Mantella, Ph.D.
-
Maria McCarthy,
M.D., Ph.D.
-
Harvey M. Morris, B.A.
-
Sharon A. Nau, M.Sc.
-
Nadezhda V. Povysheva, Ph.D.
-
Konasale M. Prasad, M.D.
-
Sarah K. Reynolds, Ph.D.
-
Diana C. Rotaru, M.D.
-
Suzy Scherf, Ph.D.
-
Michael Schonberg, Ph.D.
-
Brian H. Shirts,
B.A.
-
Martin Strassnig, M.D.
-
Laura Taylor
-
Jennifer E.
Vaughan, B.Phil.
-
Nicholas Walsh, B.Sc.
-
Ellen M. Whyte,
M.D.
-
Jennifer E. Wildes, Ph.D.
-
Patricia A Wilkosz, M.D.,
Ph.D.
-
Aleksey V. Zaitsev,
Ph.D.
Presenter:
Rebecca A. Abromitis, MLS
Education:
Clarion University of PA and University of Pittsburgh
Current
Position:
Faculty Librarian
Principal Area
of Research Interest:
Mental health information services
Current
Research Support:
Health Sciences Library System
Mentor(s):
Ammon Ripple, MLS
Direct-to-Consumer (DTC) Advertising of Psychiatric
Drugs in Popular Magazines: How are Mental Disorders
Portrayed?
RA Abromitis
University of Pittsburgh Health Sciences Library System
Study:
This small, descriptive study examines visual portrayals
of patients with mental disorders in direct-to-consumer
(DTC) psychiatric drug ads contained in popular
magazines, and compares the observable demographics with
expected prevalence in a general population.
Methods: A
hand search of popular magazines published in 2005 was
conducted to obtain DTC psychiatric drug ads that
contain both photographic depictions of patients, and
detailed drug information. The sample of 11 magazines
(257 issues) represented women’s and
men’s interests, business, health, home, lifestyle,
general, and newsweeklies. Psychiatric drug ads were
grouped according to patient portrayal and observable
demographics, and compared with expected prevalence in a
general population.
Results:
Within the resulting sample of 132 DTC psychiatric
drug ads that met inclusion criteria, 20 distinct ads
for seven drugs were identified in which: only two races
are portrayed (white and African American); 85% of
patients depicted are white; young, white, women
exclusively represent patients with bipolar disorder;
and 99% of patients display positive affect. Numerous
demographic groups are underrepresented (e.g.,
adolescents are not represented in antidepressant ads,
the aged do not appear in antidepressant or hypnotic
ads, and adults are not represented in stimulant ads).
Conclusion:
The demographics portrayed in the aggregate ads do not
adequately reflect the prevalence of mental disorders in
a general population.
Significance:
For consumers, ad imagery could lead to or reinforce
stereotypes about mental disorders, or provide
unrealistic expectations about the efficacy of drugs.
Funding Source:
University of Pittsburgh Health Sciences Library System
Presenter:
Carmen Andreescu, M.D.
Education:
“Carol Davila” University of Medicine and Pharmacy,
Bucharest, Romania
Current
Position: Psychiatric Resident PGY-4
Principal Area
of Research Interest: Depression and anxiety in
late life
Current
Research Support: None
Mentor(s):
Ellen Whyte, M.D., Eric Lenze, M.D., Charles F.
Reynolds, M.D.
Impact of
Anxiety on Response and Recurrence of Major Depressive
Disorder in Old Age: A Randomized, Double-Blind,
Placebo-Controlled Maintenance Study
C Andreescu1,
EJ Lenze1, MA Dew1, AE Begley1,
BH Mulsant1,2, AY Dombrovski1, BG
Pollock1,3, J Stack1, MD Miller1
, CF Reynolds1
1University
of Pittsburgh School of Medicine, Department of
Psychiatry; 2University of Toronto,
Center for Addiction and Mental Health, and 3The
Rotman Research Institute
Study:
This study examines whether co-morbid anxiety predicts
acute treatment response in late-life depression (LLD)
and recurrence of major depressive episodes during
two-year, randomized, placebo-controlled, double blind
maintenance treatment.
Methods:
Data were drawn from a study of protocolized
pharmacotherapy and psychotherapy for patients age 70
and over with major depressive disorder (MDD). Severity
of anxiety symptoms was measured using the Brief Symptom
Inventory. Anxiety disorders present at study entry were
diagnosed using the Structured Clinical Interview for
DSM IV. A survival analysis was used to examine the
effect of baseline co-morbid anxiety on time to response
and time to recurrence after controlling for possible
confounder variables.
Results:
Patients with higher severity of anxiety symptoms at
baseline took on average 4.3 weeks longer to respond (Wilcoxon=
6.26, df =1, p=0.012). Among patients who achieved
response, those with higher severity of anxiety symptoms
at baseline showed a significantly higher risk of
recurrence of depression during maintenance treatment
(chi-square=7.05, df=1, p=0.008, 95% CI hazard ratio =
1.22-3.72). Actuarial recurrence rates (adjusting for
censoring) were 29% (pharmacotherapy with lower BSI
scores), 58% (pharmacotherapy with higher BSI scores),
54% (placebo with lower BSI scores) and 81% (placebo
with higher BSI scores).
Conclusion:
These findings support a need for active identification
and management of anxiety symptoms in late-life
depression, both to achieve initial response and to
stabilize long-term recovery.
Funding Sources:
P30 MH52247, P30 MH071944, R37 MH43832, K24 MH069430,
R01 MH37869 and the John A. Hartford Foundation
Presenter:
Miya Asato, M.D.
Education:
Jefferson Medical College
Current Position:
Assistant Professor of Pediatrics and Psychiatry
Principal Area of
Research Interest:
Psychiatric comorbidities in neurological disease
Current Research Support:
NIH
Mentor(s):
Beatriz Luna, Ph.D., Patricia Crumrine, M.D., John
Campo, M.D.
Neurobiologic
Correlates of Cognitive and Psychiatric Comorbidity in
Pediatric Epilepsy
M Asato, P Crumrine, E Yasui, M Wilds, and
B Luna
University of
Pittsburgh School of Medicine, Department of Pediatrics
and Psychiatry
Study: Epilepsy
is a common chronic disorder occurring in children.
Individuals with epilepsy are at higher risk for
psychopathology and cognitive problems than healthy
children. However, the neurobiologic link between brain
function and behavior is not well understood. These
initial results are from an ongoing prospective study of
different subtypes of medically treated pediatric
epilepsy patients and matched controls that examines
whether performance of children with epilepsy and
controls differ on executive tasks and if this is linked
to psychopathology.
Methods: Pairs
of well characterized high-functioning pediatric
epilepsy patients ages 9-17 years and controls matched
by age, gender and IQ performed a battery of
neurocognitive tests, diagnostic psychiatric
interviewing using the Schedule for Affective Disorders
and Schizophrenia for School Age Children, Present and
Lifetime (K-SADs-PL), and oculomotor tasks including
visually guided saccades and antisaccade tasks.
Results:
Half of the epilepsy
patients were diagnosed with psychiatric disorders,
including ADHD and depression. Epilepsy subjects showed
intact performance in the visually guided saccade task
and impaired performance in the antisaccade task.
Conclusions:
Intact VGS performance indicates intact
basic sensorimotor function.
Impaired antisaccade performance indicates impaired
response inhibition.
Significance:
These findings support the
association between epilepsy and executive dysfunction
that may be concurrent with the incidence of
psychopathology.
Funding Source:
NINDS, grant K23 NS052234
Presenter:
Joshua A. Bagley, B.S.
Education:
University of Pittsburgh
Current Position:
Undergraduate
Fellow
Principal Area of
Research Interest:
Adult neurogenesis
Current Research Support:
University of Pittsburgh
NIMH Undergraduate
Fellowship
Mentor:
Nathan Urban, Ph.D.
The Fate of Adult Born
Neurons in the Olfactory System
JA Bagley¹, NN
Urban²
¹University of Pittsburgh, Department
of Neuroscience; ²Carnegie Mellon University, Department of Biological
Sciences
Study:
There appears to be a critical period for the survival
of adult generated neurons in the olfactory bulb during
which survival is more affected by sensory deprivation.
We chose to extend this idea to show the existence of a
critical period for cell fate determination of the new
neurons. With the observation that the new neurons
express different phenotypes within the granule cell
layer (GCL) and the glomerular layer (GLL), our study
shows that over a certain period beginning 14 days after BrdU injection the new neurons express different
phenotypes in changing ratios.
Methods:
Adult mice were injected with BrdU and then sacrificed
at 7, 14, 20, and 40 days after the injection. The
percentage co-expression of BrdU with each phenotypic
marker calbindin (CB), calretinin (CR), n-copine (NC),
GABA, and tyrosine hydroxylase (TH) was determined using
double immunofluorescence labeling. This was also
compared with the co-expression of the neuronal specific
marker NeuroTrace (NT) with each of the phenotypes.
Results:
The new neurons (BrdU cells) showed varied
expression of the phenotypes CB, CR, NC, GABA, and TH.
The percentage of new neurons expressing each of the
phenotypic markers changed dynamically over the period
7-40 days post BrdU injection. At 40 days post BrdU
injection, these percentages were similar to the
percentages of mature neurons (NT cells) expressing each
phenotype, suggesting that the new neurons express the
phenotype of the cells they replace. Sensory
deprivation resulted in an increase of new neurons
expressing CR, and a decrease in new neurons expressing
TH and GABA.
Conclusion:
There appears to be a critical period where the cell
fate of adult generated neurons is determined and
reflects that of the mature neurons in the bulb. The
cell fate of the new neurons may, to some extent, be
dependent on olfactory sensory activity.
Significance:
The existence of a critical period for cell fate
determination would allow for the testing of
manipulations during the period resulting in discovery
of the factors involved in cell fate determination of
adult generated neurons.
Funding Source:
NIDCD-005798
Presenter:
Mikhil N. Bamne, Ph.D.
Education:
Tata Memorial Cancer Center, Mumbai University, India
Current Position: Postdoctoral Fellow, Department of Psychiatry
Principal Area of
Research Interest:
Genetic determinants of schizophrenia
Current Research Support:
NIMH MH-56242-06
Mentor(s):
Vishwajit L. Nimgaonkar, M.D., Ph.D.
Clues for Mitochondrial DNA
Involvement in Schizophrenia Genesis
MN Bamne1, M Talkowski1, KV Chowdari1, B
Devlin1, 3, SB Manuck2, R Ferrell3, VL
Nimgaonkar1, 3
University of Pittsburgh School of Medicine, Departments of 1Psychiatry,
2Psychology, and 3Human Genetics
Study: Several lines of evidence
implicate mitochondrial dysfunction in schizophrenia (SZ). Mitochondrial DNA (mtDNA)
codes for 13 proteins that are involved in energy metabolism. We conducted a
multi-staged case-control study to identify mtDNA marker/s conferring
susceptibility to SZ. As a result of our initial findings, we focused on the
NADH Dehydrogenase subunit
5 (ND5)
gene.
Methods:
We initially sequenced the entire mtDNA genome using 38 overlapping amplicons in
pools of DNA from SZ cases (n=180) and community-based controls (n=180). Based
on our findings, we further sequenced the ND5 gene in individual subjects
from two independent groups of cases and controls (Group1: cases N=199, controls
N=317; Group 2: cases N=211, controls N= 415). Sequence variations observed were
compared with the mtDNA database (www.mitomap.org).
Results:
Using the pooled DNA sequencing method, we observed 44 common mtDNA
polymorphisms among cases and controls, of which 2 polymorphisms localized to
ND5 gene showed suggestive differences in case-control allele frequency (mtDNA
13368 G/A, p=0.019 and 13708G/A,p=0.043).
Further sequencing of the ND5 gene in individual subjects from two
independent groups of cases and controls revealed no significant difference in
allele frequency for these two variations. However, we identified 224 other rare
polymorphisms, some of which have been reported earlier in association with
other mitochondrial disorders. We also observed 46
novel non-synonymous and 88
synonymous variations.
We did not find any ND5 variant that was significantly associated with SZ.
Screening available first degrees relatives revealed 10 maternally inherited
variations. We also identified two ND5 variations that were maternally
inherited by cases and their affected siblings.
Thus, the evaluated variants are not likely to be due to somatic mutations.
Conclusion: We did not identify any DNA variation in the ND5 gene
that was significantly associated with schizophrenia. On the other hand we
observed a number of non-synonymous variations unique to cases that are not
likely to reflect somatic mutation.
Significance: The presence of non-synonymous
mtDNA variations that are unique to cases and the maternal inheritance of some
variations in the ND5 gene warrant further functional evaluation.
Funding Source: NIMH, grants/MH5624206
Presenter:
Srihari S Bangalore, M.D.
Education:
University of Pittsburgh
Current Position:
Child and Adolescent Psychiatry Fellow
Principal Area of
Research Interest:
Neurobiology of first episode psychosis
Current Research Support:
None
Mentor(s):
Matcheri S Keshavan, M.D.
Prolonged Untreated Illness Duration (DUI) Correlates
with Temporal Gray Matter Volume Loss in First Episode,
Antipsychotic Naïve Schizophrenia - A Voxel Based Morphometric Analysis
SS Bangalore1,
J Nutche1,
VA Diwadkar1, 2, KMR Prasad1, MS
Keshavan1, 2
1University
of Pittsburgh School of Medicine, Psychiatry; 2Wayne
State University, Department of Psychiatry
Study: Frontolimbic neural circuit dysfunction
has been thought to underlie schizophrenia as evidenced
by abnormalities in the frontal and temporal lobe
structures. Prolonged duration of untreated illness
(DUI) is associated with structural changes in some
(e.g.Velakoulis et al., 2002), but
not all (Ho et al., 2003) studies of schizophrenia. We
present data addressing this question in a series of
neuroleptic naïve first episode schizophrenia patients.
Methods: To determine the relationship between
DUI and gray matter changes in schizophrenia, we
analyzed the structural magnetic resonance images of 82
previously untreated first episode schizophrenia
patients by optimized voxel based morphometry. We
defined duration of untreated illness (DUI) as the time
between the initial onset of any psychiatric symptom to
the entry into the study (Haffner et al., 1992).
Results: DUI inversely correlated with
gray matter (i.e., longer the DUI, lower the gray matter
density) in the left inferior temporal gyrus (Brodmann
area 37,fusiform gyrus). This was significant after
multiple comparison correction at the voxel level (pFWE-corr=0.014,pFDR-corr=0.033
and t77=5.48). Less significant inverse
correlations were seen in the parahippocampal, lingual
and peristriate cortex (BA 19).
Conclusion: The observed inverse relationship
between DUI and temporal gray matter density suggests a
progressive neurodegenerative process during the early
course of schizophrenia, and provides a strong rationale
for early intervention (Keshavan, 1999). Larger,
prospective long-term follow-up studies are
required to further evaluate the impact of prodrome and
untreated psychoses.
Significance: Intervention, early in the course
of schizophrenia might be neuroprotective.
Funding Source: Grants MH45203, 46614 and 64023
Presenter:
Layla Banihashemi, M.S.
Education:
University of Pittsburgh
Current Position:
Center for Neuroscience (CNUP) PhD program
Principal Area of
Research Interest:
Neural circuitry involved in stress and anxiety
Current research support:
CNUP program
Mentor(s):
Mary L. Phillips, M.D.
Gray and White Matter Changes in
the “Ventral Visual Stream” and the Cerebellum in
Bipolar Patients (BP) Revealed by Voxel-Based
Morphometry (VBM)
L Banihashemi1, JRC
Almeida2, 3, D Akkal3, N Kerr3,
S Hassel3, DJ Kupfer3, ML Phillips3
1University of
Pittsburgh, Department of Neuroscience; 2University
of Sao Paulo School of Medicine, Department of
Psychiatry; 3University of Pittsburgh
School of Medicine, Department of Psychiatry
Study:
Previous neuroimaging studies have shown structural
changes in bipolar patients (BP). However, previously
reported results are inconsistent. Therefore, the
pattern of structural changes in BP remains unclear.
The goal of the present study is to reexamine white and
gray matter changes in BP using VBM and a whole-brain
approach.
Methods: We assessed 22 BP type I, and 18 healthy
controls. Brain images were acquired in a 3T Siemens
scanner, analyzed with SPM5 for spatial normalization
and segmentation of the gray and white matters.
Statistical comparisons were performed with general
linear model. Statistical level p=0.001
Results: Compared to controls, BP had
significant decreases in white matter in the right
middle temporal gyrus and left cerebellum (posterior
lobe, tonsil). Additionally, BP exhibited increased
white matter in the left cuneus, left inferior occipital
gyrus, and left superior temporal gyrus compared to
controls. BP showed significant decreases in gray matter
in the left frontal rectal gyrus, left inferior temporal
gyrus, left middle temporal gyrus, and left anterior
cerebellar vermis.
Conclusion: Our structural imaging results indicate
discrete yet specific abnormalities in BP, which include
regions of the ventral object recognition pathway, as
well as cerebellar regions involved in emotion and
oculomotor behavior.
Significance: Our findings provide a potential
anatomical basis for the deficits in emotional
processing observed in BP.
Funding Source: NARSAD, P5659590
Presenter: Richard
Blakesley-Ball, B.S.
Education: University of Pittsburgh
Current Position: Doctoral Student, Department of
Biostatistics, GSPH
Principal Area of Research Interest: Biostatistical
methodology in psychiatric research
Current Research Support: NIMH T32 MH073451
Mentor(s): Sati Mazumdar, Ph.D., Charles F.
Reynolds III, M.D.
A
Sensitivity Analysis in Neuropsychological Data to
Address Inflation of Type I Error
RE
Blakesley-Ball, S Mazumdar, MA Dew, PR Houck, MA
Butters, CF Reynolds
University of Pittsburgh, Department of Biostatistics;
and University of Pittsburgh School of Medicine,
Department of Psychiatry
Study:
Type I error inflation is a common and pressing concern
in the analysis of test data from multicomponent
neuropsychological batteries. The purpose of this
methodological study was to compare the robustness of
results across several type I error adjustment methods
in the context of interrelated outcomes. This
sensitivity analysis utilized data which came from a
cross-sectional study with 100 outpatients, age ≥ 60,
non-demented, with current, unipolar, nonpsychotic
depression, and 40 age- and education-equated controls
with no psychiatric history. Measures included 17
neuropsychological measures across five domains.
Methods: Bonferroni-based (Bonferroni, Holm,
Hochberg, Hommel) and resampling (bootstrap, stepboot)
methods were performed using proc multtest in SAS,
under alternate variance assumptions. Ad hoc
methods (D/AP, TCH, RSA), designed to incorporate
correlations, were programmed in a SAS macro. A global
test statistic, programmed in a SAS macro, was performed
to compare with the MANOVA analysis available in proc
glm in SAS.
Results:
The Bonferroni-based methods ranked from most to least
conservative were Bonferroni, Holm, Hochberg, and Hommel.
The resampling methods produced sporadic results with no
clear trend. Ad hoc methods were more liberal
than the Bonferroni-based methods, and were ranked from
most to least conservative as D/AP, RSA, and TCH.
Extreme Hochberg/Hommel p-values, significant or not,
tended to be more extreme compared to ad hoc
methods. The MANOVA and the global test results were
similar. Use of a weighted mean of the correlation
structures within each group resulted in lower global
test statistic p-values. Methods calculated under
different variance assumptions produced skewed results
when variance assumptions did not hold.
Conclusion: For interrelated outcomes, type I error
adjustments methods should be compared.
Significance: With planned simulations, the goal of
this work is to develop guidelines for the appropriate
use of methods for adjustment for type I error inflation
with correlated data.
Funding Source: NIMH T32 MH073451, NIMH ACISR P30
MH071944
Presenter:
Michael R. Bykowski, B.Phil.
Education:
University of Pittsburgh
Current Position:
Graduate Student
Principal Area of
Research Interest:
Body fluid homeostasis in rats
Current Research Support:
U.S. National
Institute of Mental Health (MH-25140)
Mentor(s):
Edward M. Stricker, Ph.D.
Visceral Inhibition of NaCl Solution Consumption in
Adrenalectomized Rats
MR Bykowski, ML Hoffmann, EM Stricker
University of Pittsburgh, Department of Neuroscience
Study: Rats consume large volumes of NaCl
solution after bilateral removal of their adrenal
glands. The present experiments sought to identify the
postingestional signals that cause adrenalectomized (adrex)
rats to stop consuming saline solution.
Methods: For 7-10 days after surgery, adrex rats
were given access to 0.15 M, 0.30 M, or 0.50 M NaCl for
5-6 hr daily; food and water were present ad libitum.
In addition, some adrex rats were given 0.05M NaCl to
drink for 1 hr daily and then, after a 30-min delay,
0.30 M NaCl was available for 5 hr.
Results: Adrex rats were observed to
consume similar amounts of 0.05M and 0.15M NaCl in a
10-min drinking test, but they drank significantly less
0.30 M NaCl and even less of 0.50 M NaCl.
Interestingly, the rats stopped consuming saline while
almost all of the ingested solution was still present in
the stomach and small intestine, and the osmolality of
systemic blood was not yet affected. Gastric emptying
varied as a function of concentration; the hypertonic
solutions emptied little in 10 min, whereas the more
dilute solutions emptied quite rapidly.
Conclusion: These and other findings suggest two
dimensions for inhibition of saline consumption by adrex
rats: distension of the stomach and small intestine, and
increased osmolality (or Na+ concentration)
of visceral blood. Summation of these early
postingestional signals may override the excitatory
stimulus for saline ingestion by adrex rats.
Significance: These observations contribute to
our overall understanding of the influences of
presystemic inhibitory signals of motivated fluid
ingestion.
Funding Source:
NIMH grant MH-25140
Presenter:
Raymond Y. Cho, M.D., M.Sc.
Education:
University of Toronto
Current Position:
Assistant Professor of Psychiatry
Principal Area of
Research Interest:
Cognitive control deficits in women diagnosed with
schizophrenia
Current Research Support:
NIMH R03 MH073955; P50
MH45156-15; R01 MH047073
Mentor(s):
Jonathan Collin, M.D., Ph.D., Cameron Carter, M.D.,
David Lewis, M.D.
Generalizability of Signaling for Control Processes
RY Cho, JM Orr, SE Forster, JD Cohen, CS Carter
University of Pittsburgh School of Medicine, Department
of Psychiatry
Study: One basic question regarding the
architecture of the cognitive control system is whether
signaling for control is context-specific versus
generalizing across contexts. We explored this issue,
employing a paradigm that exploited the Simon effect to
effect trial-to-trial performance adjustments. For
instance, incompatible trials elicit improved
performance on subsequent incompatible trials (Gratton
effect), and responses are slower after errors (Rabbitt
effect). Do such control effects—typically observed
within context—exist across contexts? Two
task-switching paradigms were used to assess the degree
to which control effects exist across contexts.
Methods: Healthy undergraduate psychology
students participated in two types of task-switching
paradigms. One paradigm (Study 1) varied context at the
stimulus-response mapping level (n=44) while the other
(Study 2) varied context at the task representation
level (n=67).
Results: For Study 1, there was evidence
of across-context control effects for both the Gratton
and Rabbitt effects. For Study 2, there was evidence
for Rabbitt effects but only suggestions of weak Gratton
effects.
Conclusion: The extent to which context-general
control effects occur depends on the control mechanism.
Rabbitt effects may involve a generic adjustment in
response biasing thus reflecting a low-level mechanism
that easily generalizes across contexts. Gratton
effects depend on higher task-level representations with
across-context control effects depending critically on
the similarity of the component contexts.
Significance: Detailed knowledge concerning the
generalizability of different control mechanisms may be
critical in formulating novel therapeutic interventions
for cognitive rehabilitation in schizophrenia and other
serious mental illnesses with disordered cognitive
control.
Funding Source: NIMH grant MH073955
Presenter:
Kodavali V. Chowdari, Ph.D.
Education:
University of Pune, India
Current Position:
Assistant Professor
Principal Area of
Research Interest:
Genetics of psychosis
Current Research Support:
NIMH, NARSAD, R25 and Alzheimer’s Association
Mentor(s):
Vishwajit Nimgaonkar, M.D., Ph.D. and David A. Lewis,
M.D.
DNA Pooling: A
Comprehensive, Multi-Stage Association Analysis of ACSL6
and SIRT5 Polymorphisms in Schizophrenia
KV
Chowdari1, A Northup1, L Pless1,
J Wood1, YH Joo1, K Mirnics1,
DA Lewis1, PR Levitt3, SA Bacanu1
and VL Nimgaonkar1, 2
University of Pittsburgh School of Medicine, Departments
of 1Psychiatry and 2Human
Genetics; 3Vanderbilt University, John F.
Kennedy Center for Research on Human Development and
Department of Pharmacology
Study: We have shown that re-sequencing is a precise
method for estimating SNP allele frequencies in pooled
DNA. We have now adapted this method for genetic
association studies. Our strategy involves rapid,
comprehensive screening of all common polymorphisms in a
defined region by pooled DNA sequencing. Suggestive
associations are followed up by individually genotyping
SNPs using the samples composing the DNA pools. If
confirmed, the associations are tested further in
independent samples. Here, we report genetic analysis of
ACSL6 (Acyl-CoA synthetase long-chain family member 6,
5q31, 43kb) and SIRT5 (sirtuin 5, 6p23, 45kb), which are
involved in the altered phospholipid metabolism and cell
signaling and thus may mediate schizophrenia
pathogenesis.
Methods: DNA pools were made by measuring DNA
concentrations using a Pico Green reagent. Pools of
cases (n=200) and controls (n=200) were amplified in
quadruplicate using the PCR. Peak heights of sequencing
traces were used to estimate allele frequencies and were
obtained from ABI Prism Sequencing Analysis software
version 3.7.
Results: We identified 38 SNPs at ACSL6 and 31 SNPs
at SIRT5 genes, by pooled sequencing (minor allele
frequency >10%). Comparison of traces from pooled
samples of cases and controls revealed suggestive
differences for nine SNPs, following comparisons of
variances and estimated error rates. These SNPs were
genotyped in individual samples (n=400). We thus
detected suggestive trends for association with ACSL6
(rs 11743803, p values allele-wise=0.02 and
genotype-wise =0.06). In an extended sample (448 cases
and 554 controls) the association remained marginally
significant.
Conclusion: Our study clearly demonstrates the
application of pooled DNA sequencing in identifying and
estimating reliable SNP allele frequencies in
case-control association studies.
Significance: Pooled DNA sequencing is a fast,
cost-effective and reliable approach for comprehensive
analysis of defined chromosomal regions in association
studies.
Funding Source: NIMH MH56242
and the Alzheimer’s Association
Presenter:
Nicole V. Christian, B.A.
Education:
University of Pittsburgh School of Medicine
Current Position:
MD Candidate, MS-III
Principal Area of
Research Interest:
ADHD in adolescents
Current Research Support:
NIMH grant MH66371
Mentor(s):
Oscar Bukstein, M.D.
ADHD in a Detention Center Population
NC Christian, O Bukstein, AL Williams, JL Baker
University of Pittsburgh School of Medicine, Department
of Psychiatry
Study: The population of incarcerated youth in
the United States continues to grow. There is an
increasing awareness of psychiatric disorders among
juvenile offenders. Psychiatric problems, particularly
Attention Deficit Hyperactivity Disorder (ADHD) may
significantly influence adolescents presenting to the
juvenile justice system and may affect their quality of
life and risks of adjudication and recidivism. This
study will determine the prevalence of ADHD and other
disruptive behavior symptoms, perceived impairment by
detainees and parent/caregivers, and history of
treatment utilization in detained youth at Shuman
Juvenile Detention Center in Pittsburgh, PA.
Methods: Approximately 100-150 youth, aged 12-18
detained at the Shuman Juvenile Detention Center of
Allegheny ann(s) were
interviewed using the Disruptive Behavior Disorder Scale
(DBD), Impairment Rating Scale (IRS), Services for
Children and Adolescents-Parent Interview (SCAPI), and
existing records from the MAYSI-2, a screen for mental
health problems in juvenile detainees.
Results: According to parental report,
nearly 50% of detained adolescents met ADHD criteria,
and over 65% of adolescents suffer from Conduct Disorder
or Oppositional Defiance Disorder. Despite this high
prevalence, only 15% are currently receiving
medications. 71% of adolescents with ADHD reported
overall impairment and slightly fewer (51%) endorsed a
need for treatment, while among parents, all of those
who endorsed ADHD diagnosis in their child reported
impairment (100%) and most reported a need for treatment
(96%).
Conclusion: Based on our most current results we
determined that there is a need for effective and
efficient methods of assessing, diagnosing and treating
juvenile detainees who suffer from ADHD and other
behavior disorders. Identifying and providing
psychiatric treatment to juvenile detainees could
improve their quality of life, reduce recidivism and
reduce costs. More attention to the diagnosis of ADHD
should be made in juvenile detention setting.
Significance: Better diagnosis and more
treatment may lessen the burden of delinquent behavior.
Funding Source:
NIMH, grant MH66371
Presenter:
Sarah M. Conklin, Ph.D.
Education:
Edinboro University, University of New Orleans, Baylor
University
Current Position:
Post Doctoral Scholar, Cardiovascular Behavioral
Medicine
Principal Area of
Research Interest:
Influence of diet on mental health and behavior
Current Research Support:
Cardiovascular Behavioral Medicine Program
Mentor(s):
Matthew F. Muldoon, M.D., M.P.H.; Stephen B. Manuck,
Ph.D.
Polyunsaturated Fatty Acids are Associated with
Normative Variation in Mood, Personality and Behavior
SA Conklin1, JI Harris2, SB
Manuck3, JK Yao6, JR Hibbeln5,
MF Muldoon1,
4
1University
of Pittsburgh School of Medicine,
Department of
Psychiatry; 2Brown University, Department of
Psychiatry; 3University of Pittsburgh,
Department of Psychology; 4Pharamceurtical
Sciences; 5National Institutes of Health,
Rockville, MD;
6VA
Pittsburgh Healthcare System
Study: Low levels of polyunsaturated fatty
acids, which are obtained in diet and concentrated in
the brain, have been linked to several neurobehavioral
disorders. Preliminary trials of ω-3 fatty acid
supplementation [Linolenic (LNA), eicosapentaenoic (EPA)
and docosahexaenoic (DHA)] for clinical depression and
other disorders have reported benefit. Here, we examine
relationships of these lipids to normative variability
of mood and personality in a non-patient community
sample.
Methods: Participants were 106 (age = 54.24 [SD
= 8.72], 50.9% female) hypercholesterolemic, but
otherwise healthy adults. Participants completed the
Beck Depression Inventory (BDI-II), the Barratt
Impulsiveness Scale (BIS) and the NEO-FFI. Fasting
serum fatty acids were assayed with gas chromatography.
Covariates were age, gender and race.
Results: Logistic regression showed
increased EPA and DHA were associated with lower odds
for scoring in the mild-to-moderate range (≥ 10) of the
BDI (EPA: OR = .51 per 1 SD increase [CI= .27 - .97,
p =.038]; DHA: OR = .42 [.21-.84, p = .015]).
Linear regression showed lower EPA (ß = -.284, ∆R2
= .078, p = .005) and DHA (ß = -.327, ∆R2
= .102, p = .001) to be associated with higher
NEO-Neuroticism scores, whereas DHA was positively
associated with NEO-Agreeableness (ß = .199, ∆R2
= .037, p = .044). LNA was negatively associated
with BIS Total (ß = -.263, ∆R2 = .068, p
=.008).
Conclusion:
These data suggest that dietary intake of ω-3 fatty
acids may be a determinant of normative variability in
affect regulation, impulse control and personality.
Significance: While the cardiovascular benefits of
ω-3s are well recognized, relatively little is known of
potential mental health effects among the general
public.
Funding Source: Public Health Service Grants
HL46328 and HL07560
Presenter:
Dianne A. Cruz, M.S.
Education:
University of Pittsburgh
Current Position:
Senior Research Principal
Principal Area of Research Interest:
Prefrontal cortical circuitry in schizophrenia
Current Research Support:
MH045156 and MH043784
Mentor(s):
David A. Lewis, M.D.
Ankyrin-G
Immunoreactivity at the Axon Initial Segment of Pyramidal Neurons in the
Prefrontal Cortex of Subjects with Schizophrenia
DA Cruz, EM Lovallo, and DA Lewis
University of Pittsburgh
School of Medicine, Department of Psychiatry
Study: Dysfunction of the prefrontal cortex (PFC) in schizophrenia
appears to be associated with alterations in both pre- and postsynaptic
markers of GABA neurotransmission at the axon initial segment (AIS) of
pyramidal neurons. Chandelier cell inhibitory terminals form vertical arrays
(cartridges) that synapse along the AIS of pyramidal neurons and regulate
pyramidal neuron output. In the PFC of subjects with schizophrenia, the
density of chandelier cartridges immunoreactive (IR) for the GABA
transporter 1 (GAT1) is decreased, whereas the IR for the α2
subunit of the GABAA receptor at the AIS is increased.
Interestingly, the AIS of pyramidal neurons are also IR for ankyrin-G, an
adaptor molecule required for inhibitory synapse formation. We have
previously reported that the IR of several markers of GABA neurotransmission
at the AIS of pyramidal neurons, including ankyrin-G, decline during
postnatal development in monkey PFC. This study examined whether the density
of AIS IR for ankyrin-G is altered in schizophrenia and whether such changes
are diagnostically-specific.
Methods: Fourteen triads of control, schizophrenic and major depressive
subjects were matched for age, sex, and postmortem interval. In addition, a
cohort of 4 cynomologous monkeys were treated with haloperidol and matched
to a control monkey based on sex, age, and weight. Human and monkey tissue
sections containing PFC area 46 were processed for ankyrin-G IR, and blind
to diagnosis or treatment group, quantitative measures were used to assess
the density and laminar distribution of ankyrin-G IR AIS.
Results: The density of ankyrin-G IR AIS was significantly
decreased in the superficial layers of PFC in subjects with schizophrenia
compared to matched control and MDD subjects. Antipsychotic medication did
not significantly alter the density of ankyrin-G IR AIS in monkey PFC.
Conclusion: Given the role of ankyrin-G in inhibitory synapse
formation, the reduction in ankyrin-G may reflect a lower density of
inhibitory synapses at the AIS, leading to an up-regulation of postsynaptic
GABAA receptors in schizophrenia.
Significance: These findings inform the mechanisms that contribute to
altered chandelier cell-pyramidal neuron inhibitory neurotransmission in
schizophrenia.
Funding Source:
NIMH, grants MH045156 and MH043784
Presenter:
Natacha M. De Genna, Ph.D.
Education:
Concordia University
Current Position:
Post-Doctoral Scholar in Alcohol Epidemiology
Principal Area of Research Interest:
Psychosocial correlates of health-risk in women
Current Research Support:
NIAAA T32 #AA07453
Mentor(s):
Marie Cornelius, Ph.D.
Marijuana Use and Risk
for STDs in Women Who Were Teenage Mothers
NM De Genna, MD Cornelius
University of Pittsburgh
School of Medicine, Department of Psychiatry
Study: Adolescent females have the highest risk for
sexually-transmitted diseases (STDs) of any other group. Substance abuse and
becoming an adolescent mother have also been implicated in risk for STDs in
young women. We report findings from a cohort study (n = 297) of
risky sex in young women who were recruited as teenage mothers, and who were
interviewed about their marijuana (MJ) use during adolescence and again as
young adults.
Methods: In this prospective study, 279 adolescent mothers (12-18 years
old; 75% African-American) were recruited from an outpatient prenatal clinic
(Time 1=T1). Data were collected on their substance use, medical
history, and psychosocial characteristics. Six years later (Time 2= T2),
these women were re-interviewed, collecting T1 core data as well
as an extensive sexual history. The main outcome variables of interest
included lifetime number of sexual partners and number of STDs diagnosed by
T2.
Results: The contribution of T1 predictors (including
initiating use of MJ by age 15) and T2 predictors (including
current use of MJ) were first examined with multiple regression analyses.
Early initiation and current use of MJ were significantly associated with
more sexual partners and diagnoses of STDs, even after controlling for race,
SES, internalizing and externalizing problems. Longitudinal and concurrent
predictors were then combined in a path model (LISREL), which revealed that
the effect of early MJ use on STDs was mediated by risky sex (number of sex
partners). Internalizing problems at T1 predicted externalizing
problems at T2, which was related to both risky sex and more STDs
by T2. Race was only partially mediated by MJ use and risky sex:
African-American women were at significantly higher risk for STDs, even
after including these covariates.
Conclusion: More internalizing problems during adolescence, early
initiation of MJ, and African-American race were all markers of elevated
risk for STDs in young adulthood.
Significance: Prevention programs should be targeted toward pregnant
adolescents with these identified risk factors to reduce the prevalence of
STDs in young women of childbearing age.
Funding Sources: NIAAA 08284, NIDA 09275, NIAAA T32 07453
Presenter:
Mark Demidovich, M.D.
Education:
Medical University of South Carolina
Current Position:
Psychiatric Resident PGY-3
Principal Area of Research Interest:
Disruptive behavior disorders
Mentor(s):
David J. Kolko, Ph.D. and Oscar G. Bukstein, M.D.
Medication Refusal in ODD or CD Children for
Comorbid ADHD
MA Demidovich, DJ Kolko, OG Bukstein, J Hart
University of Pittsburgh
School of Medicine, Department of Psychiatry Study: This study
examines medication history among ADHD children with a comorbid Disruptive
Behavior Disorder (DBD), notably, ODD or CD, who were referred to an
outpatient clinical trial for disruptive behaviors. An empirically based
open treatment regimen for ADHD was one element of a larger psychosocial
treatment protocol. Children who were vs. were not receiving medication at
intake were compared, along with those who accepted vs. refused medication
recommendations during the study. The nature and implications of these
findings for the adjunctive use of medication during psychosocial treatment
are discussed.
Methods: DBD youth
(6-11 years old) were diagnosed by K-SADS interview and randomized to one of
two service delivery conditions providing the same treatment modules in
eight clinical domains. The approximate duration of treatment was 15-40 hrs
in 24 weeks. A matched treatment-as usual (TAU) condition also was recruited
from two local clinics. The medication management domain followed a
treatment algorithm from the Multimodal Treatment Study of ADHD (MTA, 1999).
Data at baseline and conclusion of treatment are reported for demographic,
parental, family, child and medication variables.
Results: 176 youth were enrolled, 129 (73%) had ADHD and 36 (38%)
were on medications at intake. 96 were offered medications; 67 (70%)
accepted and 29 (30%) refused. At intake, both prior medication users and
medication acceptors had positive parental expectancies of medications.
There was also a trend for medication refusers being non-white. Clinically,
post treatment medication acceptors had lower parental ratings of
inattention/overactivity and teacher ratings for inattention. Other post
treatment measures had similar trends for med acceptors including reduction
of conduct symptoms.
Conclusion: The adjunctive use of ADHD medication in a psychosocial
treatment for DBD youth was found to further reduce some key ADHD sx, but
medication did not produce additive benefit for disruptive behaviors.
Medication refusers were distinguished by only one variable and remain an
ill-defined group warranting future investigation.
Significance: There are few descriptive studies for ADHD medication
refusers and none for those referred for disruptive behaviors. Our data will
lead to future conceptualization of adherence and treatment interventions
for this population.
Funding Source: NIMH grant MH057727
Presenter:
Rasim Somer Diler, M.D.
Education:
Istanbul University Faculty of Medicine
Current Position:
Clinical and Research Track Fellow (PGY4)-combined psychiatry & child
psychiatry
Principal Area of Research Interest:
Anxiety and mood disorders in children
Current Research Support:
Cukurova University Faculty of Medicine, Turkey
Mentor(s):
Ayse Avci, M.D.
Pharmacotherapy and
Regional Cerebral Blood Flow in Children with Obsessive Compulsive Disorder
RS Diler1, A Avci2, M Kibar 3
University of Pittsburgh
School of Medicine, Department of Psychiatry1; Cukurova
University Faculty of Medicine, Departments of Child 2Psychiatry
and 3Nuclear Medicine
Study: While regional cerebral blood flow (rCBF) studies on adults
involving the caudate, prefrontal, orbitofrontal, and cingulated areas have
been reported, no such published data exist on children. In this study, we
aimed to determine the significance of pre- and post-treatment regional
cerebral blood flow (rCBF) differences in children with obsessive compulsive
disorder (OCD) and compared them with healthy controls.
Methods: Eighteen drug-free obsessive-compulsive children aged 11 to
15, without comorbidity except for anxiety disorders participated in this
study. The control group consisted of 12 children, age 11 to 15, with no
medical or psychiatric illnesses. Using SPECT (Single Photon Emission
Computerized Tomography) scans with Technetium-99m-HMPAO-hexamethly
propyleneamine oxime (Tc99mHMPAO), the rCBF was calculated in 15 regions of
the control group according to a standard protocol, while in the study
group, it was measured at baseline and after 12 weeks of treatment with a
fixed dose of paroxetine (20 mg qday). We compared the resulting pre- and
post-treatment CBF values for the control and study group.
Results: The right and left caudates, right and left
dorsolateral prefrontals, and cingulate had significantly higher rCBF in
children with obsessive-compulsive disorder than in the control group. These
areas, in addition to the right anteromedial temporal, showed significant
rCBF reduction after treatment with paroxetine. The mean percentage of
change in obsession scores during the treatment correlated significantly
with the baseline and post-treatment rCBF levels of the right caudate,
post-treatment left caudate, and baseline left caudate.
Conclusion: Our findings on children are consistent with adult studies
and support the theory of a cortical-striatal-thalamic-cortical loop
disturbance in OCD.
Significance: This is the first study of cerebral blood flow and pre-
and post-treatment SPECT on OCD in children; the existence of a study group
of drug-free children with early-onset pure OCD (without comorbidity other
than anxiety disorders) strengthens the implications of our results.
Funding Source:
Cukurova University Faculty of Medicine, Turkey
*abstract only
Presenter:
Stephen M. Eggan, B.S.
Education:
University of Pittsburgh
Current Position:
Graduate Student Researcher
Principal Area of Research Interest:
Pathophysiology of schizophrenia
Current Research Support:
Scottish Rite Schizophrenia Fellowship
Mentor(s):
David A. Lewis, M.D.
Localization of the
Cannabinoid CB1 Receptor in Monkey and Human Prefrontal Cortex
SM
Eggan1, 3 and DA Lewis1, 2
University of Pittsburgh
School of Medicine, Departments of 1Neuroscience and 2Psychiatry;
3Center for the Neural Basis of Cognition
Study: Delta-9-tetrahydrocannabinol (∆9-THC)
has profound effects on cognitive functions subserved by the prefrontal
cortex (PFC), and exposure to THC has been associated with the
appearance or exacerbation of the clinical features of schizophrenia. These
actions appear to be mediated via the CB1 receptor, the principal
cannabinoid receptor expressed in the brain. In order to understand how the
CB1 receptor mediates these functions, it is necessary to know
how it is distributed throughout the primate brain.
Methods: We used immunocytochemical techniques and antibodies that
specifically recognize the C-terminus of the CB1 receptor to
examine the regional and laminar distribution of the CB1 receptor
in the neocortex of macaque monkeys and humans. In addition, we used
immunoelectron microscopy in order to determine the cellular localization
and cell types that express the CB1 receptor in the monkey PFC.
Results: In both monkeys and humans, intense CB1
immunoreactivity was observed primarily in axons and boutons. The overall
density of CB1-immunoreactive (CB1-IR) axons was much
higher in the PFC compared to most other regions, such as the primary visual
cortex (PVC). The PFC also exhibited a dense band of CB1-IR axons
in layer 4, whereas in PVC layer 4 contained the lowest density of CB1-IR
axons. In humans CB1-IR axons appeared more varicose, but this
difference appeared to be due to postmortem interval (PMI) as similar
morphological differences were present in monkey tissue with varying PMIs.
Electron microscopy studies revealed that CB1-IR was
predominantly contained in axon terminals that form symmetric synapses, many
of which were found to make proximal inputs onto cell bodies and apical
dendrites. Finally, when CB1-IR was observed in cell bodies, they
had the characteristic features of GABA neurons.
Conclusion: The high density, distinctive laminar distribution, and
localization to inhibitory terminals of CB1 receptors in the
primate PFC suggests that the CB1 receptor may play a critical
role in the circuitry that subserves cognitive functions.
Significance: Knowing that the CB1 receptor is involved in
circuitry that subserves cognition may provide clues to understanding
cognitive dysfunctions associated with schizophrenia as well as
vital information for the development of novel
drugs targeted to treat these deficits in patients with the illness.
Funding Source: NIMH
grants, MH51234 and MH43784
Presenter:
Tiffany R Farchione, M.D.
Education:
Wayne State University School of Medicine
Current Position:
PGY4 Fellow, Child and Adolescent Psychiatry
Principal Area of Research Interest:
Bipolar disorder
Current Research Support:
NARSAD Independent Investigator
Award (M. Phillips)
Mentor(s):
Mary Phillips, M.D. and Boris Birmaher, M.D.
Exploring the Neural Systems of Emotional Lability in Bipolar Disorder
University of Pittsburgh School of Medicine,
Department of Psychiatry
Study: Emotional
lability is a core clinical feature of bipolar disorder (BP), yet the neural
systems underlying this phenomenon are not yet understood. Functional
neuroimaging provides a non-invasive method to examine the neural correlates
of emotion regulation.
Methods: BP and
healthy individuals viewed facial expressions fear of varying intensities
during an event-related fMRI experiment.
Results: Group x
emotion x time interactions were observed in ventral prefrontal cortical-amygdala-visual cortical systems. Healthy subjects
had an increase in response to intensely fearful expressions, while BP
individuals’ responses to neutral faces were greater.
Conclusions: These
data support the notion that BP is associated with abnormalities in the
neural systems underlying the response to emotional stimuli.
Significance: These
results underscore the utility of functional neuroimaging techniques for
identifying potential biomarkers of bipolar disorder.
Funding Source:
NARSAD Independent Investigator Award (M.
Phillips)
Presenter:
Erika E. Forbes, Ph.D.
Education:
AB, Harvard University; Ph.D., University of Pittsburgh
Current Position:
Assistant Professor of Psychiatry
Principal Area of Research Interest:
Neurobiology of affect regulation in early-onset depression
Current Research Support:
NIMH K01 MH74769, NARSAD Junior Investigator Award
Mentor(s):
Ronald E. Dahl, M.D.
An Experience Sampling
Study of Positive Affect in Children and Adolescents with Major Depressive
Disorder
EE Forbes, JS Silk, M Bertocci, D Axelson, ND Ryan, RE Dahl
University of Pittsburgh
School of Medicine, Department of Psychiatry
Study: Although affective neuroscience emphasizes altered positive
affect (PA) as a key characteristic of depression, few studies have
addressed the experience and expression of PA in this disorder. The need to
address PA is especially important in research on adolescent depression,
which occurs at a period in which there is an increase in both rates of
major depressive disorder and frequency of PA-related behavior such as
reward-seeking. When examining depression-related disruptions to PA, it is
critical to use methods that allow the measurement of affect in natural
settings.
Methods: Using cell phones, self-reported mood and activities were
assessed in 29 children and adolescents with major depressive disorder and
16 with no history of psychiatric disorder. Participants completed an
adapted version of the Positive and Negative Affectivity Scale for Children
(PANAS-C) at 12 time points over a 4-day period.
Results: As expected, low PA was associated with major
depressive disorder. However, a group X development interaction indicated
that adolescents but not children with depression experienced lower PA than
did control participants. Furthermore, within the depressed group, higher PA
predicted better response to treatment.
Conclusion: Low PA in natural settings distinguishes adolescents with
major depressive disorder, indicating that development may play a role in
depression-altered affective systems. PA might also play a role in the
course of depression.
Significance: Findings represent a worthwhile step in elucidating the
roles of reward-seeking behavior, reward processing, and pubertal
development in depression.
Funding Source: NIMH
grants, P01 MH41712 and R24 MH67346
Presenters:
Alison Gilbert, M.S. and Teresa Lanza di Scalea, M.D.
Education:
University of Pittsburgh; University of Rome Tor Vergata
Current Position:
Graduate Student; Visiting Psychiatry Resident
Principal Area of Research Interest:
Treatment of mood disorders
Current Research Support:
NIMH R21 MH61948
Mentor(s):
Jill Cyranowski, Ph.D., Holly Swartz, M.D., Ellen Frank, Ph.D.
Impact of Interpersonal
Psychotherapy on Toronto Alexithymia Scale-20 Scores
AM Gilbert, MS1, T Lanza di Scalea, MD2, 3,
J Cyranowski, PhD1, 2, HA Swartz, MD2, E
Frank, PhD1, 2
University of Pittsburgh,
Departments of 1Psychology and 2Psychiatry, 3University
of Rome Tor Vergata, Department of Neuroscience, Psychiatry Unit
Study:
Interpersonal Psychotherapy (IPT) is an efficacious treatment
for depression that helps patients identify their own mood state and how it is
linked to interpersonal events. Clinical evidence indicates that symptoms of
panic and anxiety reduce the effectiveness of standard IPT. Alexithymia is a
construct whose features are: 1) difficulty identifying and describing feelings
(DIF) 2) difficulty distinguishing between feelings and the bodily sensations of
emotional arousal (DDF), and 3) externally oriented cognitive style (EXT). We
report findings from an open, pilot study comparing IPT for depression with
panic symptoms (IPT-PS) and standard IPT. We hypothesized that symptoms of
alexithymia improve in depressed and anxious patients treated with interpersonal
psychotherapies.
Methods: Thirty-seven adult patients (81% females) meeting SCID criteria
for Major Depressive Disorder accompanied by significant lifetime panic features
(lifetime PAS-SR > 30) were randomly assigned to one of two treatment
groups: IPT-PS (n=25) or a control condition of standard IPT (n=12). Both groups
received 16-24 weeks of psychotherapy. Subjects completed the Toronto
Alexithymia Scale (TAS-20) and measures of depression and anxiety symptoms at
three time points: time 0 (pre-treatment), time 1 (treatment visit 10), and time
2 (1-week post-treatment).
Results: Twenty-eight of the 37 subjects completed all measures for
the study. Repeated measures analyses showed significant reductions in
alexithymia (TAS-20; p=.001), depression symptoms (HRSD-17, 25; p<.001) and
anxiety symptoms (HRSA; p<.001) from baseline to post-treatment (T0-T2).
There was no effect of treatment assignment (IPT-PS, IPT) on change in
TAS-20 scores. Exploratory analysis at baseline revealed a significant positive
correlation between DIF and anxious arousal (MASQ-AROUS). At baseline no
significant correlation was found between alexithymia and depression scores.
Post-treatment significant correlations were found between alexithymia and both
anxiety and depression rating scales.
Conclusion: IPT appears to be a promising
option for reducing symptoms of alexithymia as measured in depressed and anxious
patients.
Significance: By helping patients to
identify mood states and link mood changes to interpersonal events, IPT may
reduce symptoms of alexithymia. These findings warrant further evaluation.
Funding Source: NIMH,
R21 MH61948
Presenter:
Andrew R. Gilbert, M.D.
Education:
Wayne State University School of Medicine
Current Position:
Postdoctoral Research Scholar
Principal Area of Research Interest:
Neurobiology of OCD in childhood and adolescence.
Current Research Support:
NIH K12 HD049109
Mentor(s):
Mary L. Phillips, M.D., Ph.D., Bernie Devlin, Ph.D., Boris Birmaher, M.D.,
Matcheri Keshavan, M.D., David Rosenberg, M.D.
Neural Correlates of Symptom Dimensions in
Obsessive-Compulsive Disorder (OCD): A Voxel-Based Morphometry (VBM) Study
AR
Gilbert1, ML Phillips, 1, 2, J Nutche1, V
Diwadkar1, 3, MS Keshavan1, 3, D Mataix-Cols2
1University of
Pittsburgh School of Medicine, Department of Psychiatry; 2Institute
of Psychiatry, Psychological Medicine and Psychology; 3Wayne State
University School of Medicine, Department of Psychiatry and Behavioral
Neurosciences
Study: Neuroimaging studies have identified functional
neural correlates of OCD symptom dimensions. Voxel-based morphometry (VBM)
assesses differences in gray matter concentration at a micro-structural level.
To our knowledge, this is the first VBM study to examine the neural correlates
of symptom dimensions in adult OCD subjects.
Methods: Adult OCD subjects (n=25)
were compared to healthy controls (n=20). Subject symptom dimension severity
scores were measured and subjects were subdivided into low vs. high score
groups. T1-weighted SPGR images (124 1.5mm thick coronal slices) were acquired
on a 1.5T G.E. system. VBM analysis was conducted using SPM 5. The images were
spatially normalized and then segmented into gray, white and CSF compartments
using probabilistic classification. A preset threshold (p=0.001, uncorrected)
was employed to identify suprathreshold voxels.
Results: VBM analysis revealed distinct symptom
dimension-related patterns of gray matter reductions in OCD subjects (low score
> high score): frontal-limbic (washing); frontal-supplementary motor (checking);
and frontal-occipital-cerebellar (hoarding). VBM analysis also revealed
significant negative correlations between symptom dimension severity scores and
gray matter concentrations in these distinct regions.
Conclusion: The distinct patterns of
structural alterations associated with washing and checking are consistent with
previous functional neuroimaging studies of OCD subjects.
Significance: These structural neuroimaging findings
may provide converging evidence for symptom-specific neural correlates of OCD.
Funding Sources: NIH
K12 HD049109; Wellcome Trust 064846
Presenter:
Ariel G. Gildengers, M.D.
Education:
Massachusetts Institute of Technology, New Jersey Medical School
Current Position:
Assistant Professor of Psychiatry
Principal Area of Research Interest:
Late-life bipolar disorder
Current Research Support:
NIMH K23 MH073772
Mentor(s):
Benoit H. Mulsant, M.D., David J. Kupfer, M.D.
Medical Burden in Late
Life Bipolar Disorder and Unipolar Depression
AG
Gildengers, RA Drayer, EM Whyte, A Fagiolini, E Weber, PR Houck, CF Reynolds
III, E Frank, DJ Kupfer, BH Mulsant
University of Pittsburgh
School of Medicine, Department of Psychiatry
Study: We report on the degree of medical burden experienced by elderly
bipolar patients compared with elderly unipolar depression patients.
Methods: Fifty four patients with bipolar I or II disorder, ages 60 years
and older, who have been participating in the Bipolar Disorder for
Pennsylvanians (BDCP) were matched (1:2) to 108 patients with unipolar,
non-psychotic depression on age, gender, race, and duration of mood disorder
illness. Patients with unipolar depression have been participants in research
protocols of the Advanced Center for Services and Intervention Research for
Late-Life Mood Disorders (ACISR/LLMD) at the University of Pittsburgh. Variables
examined included: height, weight, body mass index (BMI), systolic/diastolic
blood pressure (BP), and cumulative illness rating scale-geriatric (CIRS-G)
total scores and individual items. Groups were compared with t-test and Chi
square statistics.
Results: After controlling for multiple comparisons, only weight was
significantly higher in the bipolar group than unipolar (t=2.81, df 155,
p=0.006). There were no significant differences in systolic/diastolic BP, height
or BMI. There was no difference between the two groups on total score of the
CIRS-G; however, respiratory (t=3.58, d=160, p=0.0005) and endocrine/metabolic
(t=4.43, df=160, p=0.0001) items were higher in the bipolar group. Heart, renal,
and eyes/ears/nose/throat, were higher in the unipolar group, but did not
achieve statistical significance, when controlling for multiple comparisons.
Conclusion: With the exception of respiratory and endocrine/metabolic
illness burden, medical burden appears comparable between elderly patients with
bipolar and those with unipolar depression, when they are matched for duration
of mood disorder illness. Greater history of smoking in the bipolar group may
underlie the higher degree of respiratory illness burden. Additionally,
treatment with mood-stabilizer and atypical antipsychotics in the bipolar group
may underlie the endocrine/metabolic illness burden, with higher rates of
hypothyroidism and diabetes mellitus.
Significance: Although these data suggest that increased medical burden is
common to late-life bipolar disorder and unipolar depression, patients with
late-life bipolar disorder may be at increased risk for respiratory and
endocrine/metabolic illness burden compared to patients with unipolar
depression.
Funding Source: NIMH, grants K23 MH
073772, P30 MH52247, P30 MH071944, K01 MH01684, K24 MH069430, R01 MH072947,
MH043832, and the Commonwealth Center of Excellence for Bipolar Disorder
from the Pennsylvania Department of Health, grant ME‑02385
Presenter:
Christin A. Glorioso, B.S.
Education:
University of Michigan
Current Position:
MD/PhD Student University of Pittsburgh
Principal Area of Research Interest:
Mood disorders and aging in the CNS
Current Research Support:
NIMH K01 MH-067721 (ES) and PAR-02-122 (ES)
Mentor(s):
Etienne Sibille, Ph.D.
Specificity and Timing of Neocortical Transcriptome Changes in Response to BDNF
Gene Ablation during Embryogenesis or Adulthood
C Glorioso1, M Sabatini1,2,
T Unger1, T Hashimoto1, LM Monteggia4, DA Lewis1,3
, K Mirnics 1,2
University of Pittsburgh School of Medicine,
Departments of 1Psychiatry, 2Neurobiology,3Neuroscience; 4UT Southwestern Medical Center, Department of
PsychiatryStudy:
Brain-derived neurotrophic factor (BDNF) is a growth factor that is critical
for the development of cortical inhibitory neurons and has reduced expression in
the prefrontal cortex of subjects with schizophrenia. To assess the role of BDNF
on gene expression in the adult mouse brain, we performed a transcriptome
profiling of mice with inducible deletion of BDNF.
Methods: BDNF was deleted in adulthood or at embryonic day 18, and we
analyzed the neocortical transcriptome in the adult mouse brain using
high-density oligonucleotide microarray profiling. Results were confirmed using
qPCR and in situ hybridization.
Results: His study revealed that: 1) the
transcriptomes of the mice with adult and embryonic BDNF-deletion show highly
correlated similarities, including altered expression of the transcripts
encoding neuropeptides, early-immediate genes and critical cellular signaling
systems; 2) the embryonic BDNF KO animals, when compared to the adult BDNF KO
mice, reported significant expression changes in several genes related to
neuronal differentiation, and 3) BDNF appears to be critical for
maintaining somatostatin-neuropeptide Y-tachykinin (SST-NPY-TAC1)
expression in interneurons in both embryonic and adult KO mice.
Conclusion: DNF expression is important for
development, maintenance of the SST-NPY-TAC1 interneuronal phenotype, and may be
critical for normal functioning of cortical neurons.
Significance: The
concept of BDNF as a critical “phenotype maintenance factor” is novel and
warrants further follow-up. Furthermore, these data are important for
understanding the role of BDNF-dependent pathophysiological changes in affective
disorders and schizophrenia.
Funding Source: NIMH Conte CNMD, Project
2
Presenter: Indrani Halder,
Ph.D.
Education:
Pennsylvania State University
Current Position: Postdoctoral Fellow: CBM Research
Training Program
Principal Area of Research Interest:
Gene-environment interactions in complex diseases
Current Research Support:
NIH Postdoctoral fellowship (T-32; HL40962)
Mentor(s):
Stephen Manuck, Ph.D., Robert Ferrell, Ph.D.
Polymorphism in Serotonin
Receptor 2A Gene is Associated with the Metabolic Syndrome
I
Halder1, S Manuck1, M Muldoon1, R Ferrell2
University of Pittsburgh, Departments of 1Psychology
and 2Human Genetics
Study: The Metabolic Syndrome is a complex aggregate of several
abnormalities involving abdominal obesity, altered glucose and lipid metabolism
and elevated blood pressure. Several psychological variables like depression and
anxiety also covary with the Metabolic Syndrome. It is possible that the central
nervous system may be involved, through the action of the serotonergic system,
in regulating blood pressure, metabolism, dietary and physical activity habits
to influence the Metabolic Syndrome.
Methods: 1165 individuals from the Adult Health and Behavior (AHAB)
registry of the University of Pittsburgh were genotyped for two polymorphisms
within HTR2A gene: G2416A and C1438T. Logistic regressions were performed
for each locus to test for the effect of each allele, after controlling for age,
sex, race and years of education. Analyses were repeated within each racial
group (214 African Americans and 951 European Americans).
Results: In the combined sample, presence of the G allele of G2416A
polymorphism is significantly associated with an increased prevalence of the
Metabolic Syndrome (OR 1.74, P = 0.005), but no associations
are seen with the C1438T polymorphism. This association is present in European
Americans (OR = 1.3, P = 0.006) but not in African Americans.
Conclusion: Variations within HTR2A gene may be differentially associated
with the Metabolic Syndrome in different populations.
Significance: This is the first study demonstrating an association between
HTR2A polymorphisms and the Metabolic Syndrome and establishes a molecular
mechanism by which the CNS modulates metabolic processes.
Funding Source: NIH
grants HL40962, HL07560
Presenter: Takanori Hashimoto, M.D., Ph.D.
Education: Niigata University, Graduate University
for Advanced Studies (Japan)
Current Position: Research Assistant Professor of
Psychiatry
Principal Area of Research Interest: Prefrontal
neuropathology of schizophrenia
Current Research Support: The
Center for the Neuroscience of Mental Disorders
Mentor(s): David A. Lewis, M.D.
Analysis of GABA-Related Transcriptome in the Prefrontal
Cortex of Subjects with Schizophrenia
T Hashimoto1, D Arion1, T Unger1,
HM Morris2, JG Maldonado-Avilles2, DW Volk1,
K Mirnics1,3, DA Lewis1,2
University of Pittsburgh School of Medicine, Departments
of 1Psychiatry, 2Neuroscience, and 3Neurobiology
Study: In the
prefrontal cortex (PFC) of subjects with schizophrenia, alterations in
inhibitory circuitry have been indicated by the decreased gene expression for
the 67 kilodalton isoform of gultamic acid decacrboxylase (GAD67), an
enzyme for GABA synthesis, and GABA transporter 1 (GAT1). However, further
understanding of the alterations in inhibitory circuitry in schizophrenia
requires systematic expression analysis of a number of GABA-related genes, such
as those encoding markers of different subsets of GABA neurons and molecules
involved in GABA transmission.
Method: The expression
of multiple GABA-related genes was analyzed in the PFC of 14 pairs of
schizophrenic and control subjects matched for age, sex and postmortem interval
using a customized DNA microarray.
Results: Our microarray
analysis replicated the previously reported deficits in GAD67 and
GAT1 mRNA expression. In addition, it revealed decreased mRNA expression for
neuropeptides, such as somatostatin, neuropeptide Y and cholecystokinin, and for
GABAA receptor subunits, including α1 and δ. These findings were
confirmed by qPCR and/or in situ hybridization. Furthermore, the
expression of GAD67, somatostatin or GABAA receptor α1
subunit mRNAs in the PFC of antipsychotic-exposed monkeys did not differ from
control animals.
Conclusions: In
the PFC of subjects with schizophrenia, levels of multiple mRNAs encoding
neuropeptides and GABAA receptor subunits were significantly
decreased. This GABA-related transcriptome appears to be associated with the
disease process rather than the treatment.
Significance: These
findings indicate that the alterations in inhibitory circuitry in schizophrenia
involve a subset of GABA neurons that co-express somatostatin and neuropeptide
Y, and postsynaptic GABAA receptors that mediate both phasic and
tonic inhibition.Funding Source: NIMH grants, MH45156 and MH43784
(DAL), and Young Investigator Award from NARSAD Essel Foundation (TH)
Presenter:
Michelle Horner, D.O.
Education:
University of Pittsburgh School of Medicine
Current Position:
Child and Adolescent Psychiatry Fellow
Principal Area of Research Interest:
Early intervention in mood disorders
Current Research Support:
Supported by NIMH grant MH60952, Boris Birmaher, M.D.
Mentor:
David Axelson, M.D.
Family adaptability and
cohesion in families with bipolar parents
M Horner, D Axelson, C Kalas,
K Monk, M Ehmann, S Iyengar, D Kupfer, D Brent, B Birmaher
University of
Pittsburgh School of Medicine, Department of Psychiatry
Study: Family
environment is considered an important aspect of childhood development and may
contribute to psychopathology in high-risk offspring. When compared to healthy
controls and normative data, two smaller cross-sectional studies have reported
lower cohesion, lower organization, and increased levels of conflict in families
with bipolar parents. Our study focuses family cohesion and adaptability in a
large sample of bipolar and community-control parent probands and their
offspring. We report baseline data from a longitudinal study.
Methods: Using the
Family Adaptability and Cohesion Evaluation Scales-II from the intake assessment
of a larger bipolar offspring study, we assessed parent and child report from
family cohesion and adaptability subscales in a sample of 306 bipolar offspring
|